Dr Susan Heavey is a lecturer in translational medicine at UCL. She set up this research team in 2020. Find out more!
Vithurran Thavarajah began his PhD in this team in 2021. He is researching how the hallmarks of cancer can be best recapitulated ex vivo.
Dr Uzoamaka Okoli joined the team in 2022 as a Research Fellow, on sabbatical from her role as Senior Lecturer in the University of Nigeria. She is researching spatial transcriptomics in cancer.
Dr Gokhan Akman joined the team in 2021 as an honorary Research Associate. He is researching spatial transcriptomics in cancer.
Lara Pierantoni joined the team in 2022 as a travel scholar, during her PhD with the 3Bs Research Group in Portugal. Here, she is investigating clinical breast cancer data.
Krishshan Gobalakrishnan is carrying out a PhD rotation in the team during 2022, as part of the MRC Doctoral Training Programme. He is researching 3D models of prostate cancer.
Premkamon (Bow) Chaipanichkul began working with the team in 2021, during her PhD with Dr Kate Rickett’s group. She is co-supervised by Dr Heavey & is working with this team to characterise the biology of her 3D nanoparticle enhanced radiotherapy models.
Tan Xu began working with the team in 2021, during her PhD with Dr Kate Rickett’s group. She is co-supervised by Dr Heavey & is working with this team to characterise the biology of her 3D nanoparticle enhanced radiotherapy models.
Andrei Enica carried out a PhD rotation in the team during 2021-2022, as part of the MRC Doctoral Training Programme. He was researching 3D models of prostate cancer & spatial transcriptomics.
Lina Pak joined the team for the full 2021/2022 academic year as a final year BSc student, researching sustainable alternative reagents for 3D culture of cancer cells.
Katarina Pedersen joined the team for the full 2021/2022 academic year as an MSci student, researching sustainable cell culture methods. She published an editorial on her work, which you can read here.
Supriya Potamsetty joined the team in 2022 as an intercalating medical student. She is researching co-targeted therapies in prostate cancer.
Thiara Rupasinghe joined the team in 2022 as an intercalating medical student. She is researching co-targeted therapies in prostate cancer.
Bavin Pathmaraj joined the team in 2022 as an intercalating medical student. He is researching co-targeted therapies in prostate cancer.
Devansh Tandon joined the team in 2022 as an intercalating medical student. He is researching co-targeted therapies in prostate cancer.
Michael Chiu joined the team in 2022 as an intercalating medical student. He is researching 3D models of prostate cancer.